289 related articles for article (PubMed ID: 26610392)
1. Functional analysis of the 11q23.3 glioma susceptibility locus implicates PHLDB1 and DDX6 in glioma susceptibility.
Baskin R; Woods NT; Mendoza-Fandiño G; Forsyth P; Egan KM; Monteiro AN
Sci Rep; 2015 Nov; 5():17367. PubMed ID: 26610392
[TBL] [Abstract][Full Text] [Related]
2. Fine mapping of a region of chromosome 11q23.3 reveals independent locus associated with risk of glioma.
Chen H; Sun B; Zhao Y; Song X; Fan W; Zhou K; Zhou L; Mao Y; Lu D
PLoS One; 2012; 7(12):e52864. PubMed ID: 23300798
[TBL] [Abstract][Full Text] [Related]
3. Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients.
Viana-Pereira M; Moreno DA; Linhares P; Amorim J; Nabiço R; Costa S; Vaz R; Reis RM
Mol Biol Rep; 2020 Feb; 47(2):877-886. PubMed ID: 31721021
[TBL] [Abstract][Full Text] [Related]
4. Pleckstrin homology-like domain family B member 1 rs498872 polymorphism and glioma risk in Chinese Han population.
Zhang JW; Liu ZH; Lin XH; Du YP; Guo HT
Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):7-9. PubMed ID: 28886307
[TBL] [Abstract][Full Text] [Related]
5. Three SNPs in chromosome 11q23.3 are independently associated with systemic lupus erythematosus in Asians.
Zhang J; Zhang Y; Yang J; Zhang L; Sun L; Pan HF; Hirankarn N; Ying D; Zeng S; Lee TL; Lau CS; Chan TM; Leung AM; Mok CC; Wong SN; Lee KW; Ho MH; Lee PP; Chung BH; Chong CY; Wong RW; Mok MY; Wong WH; Tong KL; Tse NK; Li XP; Avihingsanon Y; Rianthavorn P; Deekajorndej T; Suphapeetiporn K; Shotelersuk V; Ying SK; Fung SK; Lai WM; Garcia-Barceló MM; Cherny SS; Tam PK; Cui Y; Sham PC; Yang S; Ye DQ; Zhang XJ; Lau YL; Yang W
Hum Mol Genet; 2014 Jan; 23(2):524-33. PubMed ID: 24001599
[TBL] [Abstract][Full Text] [Related]
6. Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 complex recruitment.
Zhou C; Zhang Y; Dai J; Zhou M; Liu M; Wang Y; Chen XZ; Tang J
Sci Rep; 2016 Feb; 6():22066. PubMed ID: 26902498
[TBL] [Abstract][Full Text] [Related]
7. Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population.
Chen H; Chen Y; Zhao Y; Fan W; Zhou K; Liu Y; Zhou L; Mao Y; Wei Q; Xu J; Lu D
Am J Epidemiol; 2011 Apr; 173(8):915-22. PubMed ID: 21350045
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide association study identifies five susceptibility loci for glioma.
Shete S; Hosking FJ; Robertson LB; Dobbins SE; Sanson M; Malmer B; Simon M; Marie Y; Boisselier B; Delattre JY; Hoang-Xuan K; El Hallani S; Idbaih A; Zelenika D; Andersson U; Henriksson R; Bergenheim AT; Feychting M; Lönn S; Ahlbom A; Schramm J; Linnebank M; Hemminki K; Kumar R; Hepworth SJ; Price A; Armstrong G; Liu Y; Gu X; Yu R; Lau C; Schoemaker M; Muir K; Swerdlow A; Lathrop M; Bondy M; Houlston RS
Nat Genet; 2009 Aug; 41(8):899-904. PubMed ID: 19578367
[TBL] [Abstract][Full Text] [Related]
9. An Updated and Comprehensive Meta-Analysis of Association Between Seven Hot Loci Polymorphisms from Eight GWAS and Glioma Risk.
Wu Q; Peng Y; Zhao X
Mol Neurobiol; 2016 Sep; 53(7):4397-405. PubMed ID: 26243184
[TBL] [Abstract][Full Text] [Related]
10. The PHLDB1 rs498872 (11q23.3) polymorphism and glioma risk: A meta-analysis.
Gao X; Mi Y; Yan A; Sha B; Guo N; Hu Z; Zhang N; Jiang F; Gou X
Asia Pac J Clin Oncol; 2015 Dec; 11(4):e13-21. PubMed ID: 24935770
[TBL] [Abstract][Full Text] [Related]
11. Analysis of 60 reported glioma risk SNPs replicates published GWAS findings but fails to replicate associations from published candidate-gene studies.
Walsh KM; Anderson E; Hansen HM; Decker PA; Kosel ML; Kollmeyer T; Rice T; Zheng S; Xiao Y; Chang JS; McCoy LS; Bracci PM; Wiemels JL; Pico AR; Smirnov I; Lachance DH; Sicotte H; Eckel-Passow JE; Wiencke JK; Jenkins RB; Wrensch MR
Genet Epidemiol; 2013 Feb; 37(2):222-8. PubMed ID: 23280628
[TBL] [Abstract][Full Text] [Related]
12. A PHLDB1 variant associated with the nonfunctional pituitary adenoma.
Kim LH; Kim JH; Namgoong S; Cheong HS; Yoon SJ; Kim EH; Kim SH; Kim SH; Chang JH; Shin HD
J Neurooncol; 2019 Apr; 142(2):223-229. PubMed ID: 30868356
[TBL] [Abstract][Full Text] [Related]
13. DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells.
Iio A; Takagi T; Miki K; Naoe T; Nakayama A; Akao Y
Biochim Biophys Acta; 2013 Oct; 1829(10):1102-10. PubMed ID: 23932921
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factors.
Manjunath M; Yan J; Youn Y; Drucker KL; Kollmeyer TM; McKinney AM; Zazubovich V; Zhang Y; Costello JF; Eckel-Passow J; Selvin PR; Jenkins RB; Song JS
Neuro Oncol; 2021 Apr; 23(4):638-649. PubMed ID: 33130899
[TBL] [Abstract][Full Text] [Related]
15. Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis.
Mayes MD; Bossini-Castillo L; Gorlova O; Martin JE; Zhou X; Chen WV; Assassi S; Ying J; Tan FK; Arnett FC; Reveille JD; Guerra S; Teruel M; Carmona FD; Gregersen PK; Lee AT; López-Isac E; Ochoa E; Carreira P; Simeón CP; Castellví I; González-Gay MÁ; ; Zhernakova A; Padyukov L; Alarcón-Riquelme M; Wijmenga C; Brown M; Beretta L; Riemekasten G; Witte T; Hunzelmann N; Kreuter A; Distler JH; Voskuyl AE; Schuerwegh AJ; Hesselstrand R; Nordin A; Airó P; Lunardi C; Shiels P; van Laar JM; Herrick A; Worthington J; Denton C; Wigley FM; Hummers LK; Varga J; Hinchcliff ME; Baron M; Hudson M; Pope JE; Furst DE; Khanna D; Phillips K; Schiopu E; Segal BM; Molitor JA; Silver RM; Steen VD; Simms RW; Lafyatis RA; Fessler BJ; Frech TM; Alkassab F; Docherty P; Kaminska E; Khalidi N; Jones HN; Markland J; Robinson D; Broen J; Radstake TR; Fonseca C; Koeleman BP; Martin J
Am J Hum Genet; 2014 Jan; 94(1):47-61. PubMed ID: 24387989
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis.
Walsh KM; Rice T; Decker PA; Kosel ML; Kollmeyer T; Hansen HM; Zheng S; McCoy LS; Bracci PM; Anderson E; Hsuang G; Wiemels JL; Pico AR; Smirnov I; Molinaro AM; Tihan T; Berger MS; Chang SM; Prados MD; Lachance DH; Sicotte H; Eckel-Passow JE; Wiencke JK; Jenkins RB; Wrensch MR
Neuro Oncol; 2013 Aug; 15(8):1041-7. PubMed ID: 23733245
[TBL] [Abstract][Full Text] [Related]
17. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.
Ghasimi S; Wibom C; Dahlin AM; Brännström T; Golovleva I; Andersson U; Melin B
J Neurooncol; 2016 May; 127(3):483-92. PubMed ID: 26839018
[TBL] [Abstract][Full Text] [Related]
18. Investigation of established genetic risk variants for glioma in prediagnostic samples from a population-based nested case-control study.
Wibom C; Späth F; Dahlin AM; Langseth H; Hovig E; Rajaraman P; Johannesen TB; Andersson U; Melin B
Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):810-6. PubMed ID: 25713050
[TBL] [Abstract][Full Text] [Related]
19. Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26.
Alpen K; Vajdic CM; MacInnis RJ; Milne RL; Koh ES; Hovey E; Harrup R; Bruinsma F; Nguyen TL; Li S; Joseph D; Benke G; Dugué PA; Southey MC; Giles GG; Rosenthal M; Drummond KJ; Nowak AK; Hopper JL; Kapuscinski M; Makalic E
Neuro Oncol; 2023 Jul; 25(7):1355-1365. PubMed ID: 36541697
[TBL] [Abstract][Full Text] [Related]
20. Genetic risk profiles identify different molecular etiologies for glioma.
Simon M; Hosking FJ; Marie Y; Gousias K; Boisselier B; Carpentier C; Schramm J; Mokhtari K; Hoang-Xuan K; Idbaih A; Delattre JY; Lathrop M; Robertson LB; Houlston RS; Sanson M
Clin Cancer Res; 2010 Nov; 16(21):5252-9. PubMed ID: 20847058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
